Abstract
The emergence of pathogenic fungi resistant to a limited number of antifungal agents represents a significant threat to human health. This scenario highlights the need to develop new antifungal drugs that act on molecular targets and guarantee therapeutic efficacy and selectivity. The identification of natural products with antifungal properties, integrating modern multidisciplinary aspec…